Evaluation of the Effect of Pentoxifylline on Cisplatin-Induced Testicular Toxicity in Rats

Ali Reza Fallahzadeh,Zohreh Rezaei,Hamid Reza Rahimi,Mehrazd Jafari Barmak,Hossein Sadeghi,Sadrollah Mehrabi,Seyed Mohammadreza Rabani,Iraj Ragerdi Kashani,Vahid Barati,Reza Mahmoudi 한국독성학회 2017 Toxicological Research Vol.33 No.3

Chemotherapy is associated with male infertility. Cisplatin (cis-diamminedichloro-platinum (II) (CDDP) as a chemotherapy medication used to treat a number of cancers has been reported to most likely induce testicular toxicity. Administration of antioxidants, such as pentoxifylline (PTX) may reduce some Adverse Drug Reactions (ADRs) of CDDP. Therefore, this study investigated the potentially protective effects of PTX on CDDP-induced testicular toxicity in adult male rats. For this purpose, 42 male rats were randomly divided into 7 groups. The rats were orally pretreated with PTX at the 3 doses of 75, 150, and 300 mg/kg once a day for 14 successive days. On the 14<SUP>th</SUP> day of the study, they were intraperitoneally (IP) administered with a single dose of CDDP (7 mg/kg). Finally, the sperm/testis parameters, serum levels of reproductive hormones, including testosterone, Luteinizing Hormone (LH), and Follicle Stimulating Hormone (FSH) as the pivotal endocrine factors controlling testicular functions, and histopathological changes of testis tissue were examined. Pretreatment with the two doses of 75 and 150 mg/kg PTX indicated significant increases in the sperm count and motility induced by CDDP administration. The right and significantly left testis weights were decreased following the treatment with 300 mg/kg of PTX plus CDDP. However, 75 mg/kg of PTX plus CDDP showed the best near-to-normal histopathological features. The results demonstrated that PTX alone enhanced some parameters, such as the sperm count, while reducing other parameters, including sperm fast motility and germ layer thickness. Furthermore, despite testosterone or LH levels, the mean serum FSH level was significantly augmented by the doses of 75 and 150 mg/kg. It was concluded that PTX administration cannot reduce CDDP-induced testicular toxicity even at high doses (e.g., 300 mg/kg), while it seemed to partially intensify CDDP toxicity effects at a dose of 75 mg/kg. Thus, further research is required in this regard.

Evaluation of the Effect of Pentoxifylline on Cisplatin-Induced Testicular Toxicity in Rats

Fallahzadeh, Ali Reza,Rezaei, Zohreh,Rahimi, Hamid Reza,Barmak, Mehrazd Jafari,Sadeghi, Hossein,Mehrabi, Sadrollah,Rabani, Seyed Mohammadreza,Kashani, Iraj Ragerdi,Barati, Vahid,Mahmoudi, Reza Korean Society of ToxicologyKorea Environmental Mu 2017 Toxicological Research Vol.33 No.3

Chemotherapy is associated with male infertility. Cisplatin (cis-diamminedichloro-platinum (II) (CDDP) as a chemotherapy medication used to treat a number of cancers has been reported to most likely induce testicular toxicity. Administration of antioxidants, such as pentoxifylline (PTX) may reduce some Adverse Drug Reactions (ADRs) of CDDP. Therefore, this study investigated the potentially protective effects of PTX on CDDP-induced testicular toxicity in adult male rats. For this purpose, 42 male rats were randomly divided into 7 groups. The rats were orally pretreated with PTX at the 3 doses of 75, 150, and 300 mg/kg once a day for 14 successive days. On the $14^{th}$ day of the study, they were intraperitoneally (IP) administered with a single dose of CDDP (7 mg/kg). Finally, the sperm/testis parameters, serum levels of reproductive hormones, including testosterone, Luteinizing Hormone (LH), and Follicle Stimulating Hormone (FSH) as the pivotal endocrine factors controlling testicular functions, and histopathological changes of testis tissue were examined. Pretreatment with the two doses of 75 and 150 mg/kg PTX indicated significant increases in the sperm count and motility induced by CDDP administration. The right and significantly left testis weights were decreased following the treatment with 300 mg/kg of PTX plus CDDP. However, 75 mg/kg of PTX plus CDDP showed the best near-to-normal histopathological features. The results demonstrated that PTX alone enhanced some parameters, such as the sperm count, while reducing other parameters, including sperm fast motility and germ layer thickness. Furthermore, despite testosterone or LH levels, the mean serum FSH level was significantly augmented by the doses of 75 and 150 mg/kg. It was concluded that PTX administration cannot reduce CDDP-induced testicular toxicity even at high doses (e.g., 300 mg/kg), while it seemed to partially intensify CDDP toxicity effects at a dose of 75 mg/kg. Thus, further research is required in this regard.

A Case of Fatal Strongyloidiasis in a Patient with Chronic Lymphocytic Leukemia and Molecular Characterization of the Isolate

Eshrat Beigom Kia,Hamid Reza Rahimi,Hossein Mirhendi,Mohammad Reza Nilforoushan,Ardeshir Talebi,Farzaneh Zahabiun,Hamid Kazemzadeh,Ahmad Reza Meamar 대한기생충학열대의학회 2008 The Korean Journal of Parasitology Vol.46 No.4

Effects of Antibiotic Consumption on Children 2-8 Years of Age Developing Asthma

Hamid Reza Khalkhali,Sima Oshnouei,Shaker Salarilak,Mohammadhossein Rahimi Rad,Mohammad Karamyar,Javad Khashabi 한국역학회 2014 Epidemiology and Health Vol.36 No.-

OBJECTIVES: Antibiotic exposure in children is a possible contributor to the increasing asthma prevalence in several countries. The present study aimed to investigate the association between antibiotic exposure and the risk of developing childhood asthma at 2-8 years of age. METHODS: A case-control study was undertaken among children aged 2-8 years old between March and September 2010 in the Urmia district in the northwest of Iran. The cases were doctor-diagnosed asthmatic children based on Global Initiative for Asthma criteria (n=207), and the controls were children without respiratory symptoms (n=400) selected by frequency matching by age and gender. Clinical data including antibiotic exposure was collected by a validated and reliable questionnaire, which was completed by interviewing parents/guardians. RESULTS: Antibiotic consumption during the first year of life increased the odds ratio [OR] of asthma symptoms at 2-8 years of age (crude OR, 2.26; 95% confidence interval [CI], 1.53-3.35; p<0.01), and the strength of association was similar after adjusting for a family history of asthma or atopic disorder, preterm delivery, birth order, and delivery method (adjusted OR, 1.91; 95% CI, 1.27-2.88; p=0.03). CONCLUSIONS: Our study suggests that antibiotic consumption in children was associated with an increased risk of childhood asthma, and an additional confirmative study is needed.

Degradation of drag reducing polymers in aqueous solutions

Hamid Reza Karami,Masoud Rahimi,Saeed Ovaysi 한국화학공학회 2018 Korean Journal of Chemical Engineering Vol.35 No.1

The performance of drag reducing polymers in turbulent flow is restricted by their mechanical degradation. This study examines how the working fluid can affect the degradation behavior of diluted drag reducing polymeric solutions. Solutions having different proportions of tap water and de-ionized water served as the working fluids. Three commercially available water soluble polymeric agents, namely, an anionic copolymer of polyacrylamide, xanthan gum, and polyethylene oxide, were then added to these solutions. All experiments had identical flow rates corresponding to turbulent conditions in a laboratory scale pipe line. Variation of pressure drop in the pipe line was then measured for 2 hours. It was found that polymer degradation is accelerated in tap water solutions compared to that in de-ionized water solutions. However, this is dependent on the specification of the polymer used, namely, the molecular weight of the polymer and the rigidity of its molecular backbone. Furthermore, a new mathematical relation has been developed to investigate degradation of the polymers over time.

Development of an electrochemical fentanyl nanosensor based on MWCNT-HA/ Cu-H3BTC nanocomposite

Maryam Akbari,Maryam Saleh Mohammadnia,Masoumeh Ghalkhani,Mohammad Aghaei,Esmail Sohouli,Mehdi Rahimi-Nasrabadi,Mohsen Arbabi,Hamid Reza Banafshe,Ali Sobhani-Nasab 한국공업화학회 2022 Journal of Industrial and Engineering Chemistry Vol.114 No.-

Fentanyl is a potent narcotic drug with the same effects as morphine or heroin, but it’s significantly morepotent than these drugs. That means a tiny dose can have a dangerous impact and is also lethal, so it isessential to measure it. In this work, we have developed a new electrochemical sensor to measure thisdeadly drug utilizing a nanocomposite of multi-walled carbon nanotube, hydroxyapatite, and copperbasedmetal–organic framework (MWCNT-HA/Cu-H3BTC). The nanocomposite was first examined byX-ray diffraction, field emission scanning electron, Infrared, and Raman spectroscopic techniques. Theglassy carbon electrode (GCE) modified with MWCNT-HA/Cu-H3BTC was employed to determine fentanylin aqueous solutions. The highest oxidation current was generated for fentanyl at GCE/MWCNT-HA/Cu-H3BTC compared to the GCE, GCE/MWCNT, GCE/MWCNT/HA, and GCE/Cu-H3BTC. The GCE/MWCNT-HA/Cu-H3BTC showed a linear relationship between the concentration and the oxidation current of fentanylin the 0.01 to 100 lM with a detection limit of 3 nM. Finally, the fentanyl quantification in blood serumsamples was successfully performed. The GCE/MWCNT-HA/Cu-H3BTC’s reproducibility and stability wereindeed excellent.

A review on the pharmacokinetic properties and toxicity considerations for chloroquine and hydroxychloroquine to potentially treat coronavirus patients

Askarian Fatemeh,Firoozi Zahra,Ebadollahi-Natanzi Alireza,Bahrami Solmaz,Rahimi Hamid-Reza 한국독성학회 2022 Toxicological Research Vol.38 No.2

The SARS-CoV-2 virus, caused a novel emerged coronavirus disease, is growing rapidly worldwide. Few studies have evaluated the efficacy and safety of Chloroquine (CQ), an old antimalarial drug, and Hydroxychloroquine (HCQ) in the treatment of COVID-19 infection. HCQ is derived from CQ by adding a hydroxyl group into it and is a less toxic derivative of CQ for the treatment of COVID-19 infection because it is more soluble. This article summarizes pharmacokinetic properties and toxicity considerations for CQ and HCQ, drug interactions, and their potential efficacy against COVID-19. The authors also look at the biochemistry changes and clinical uses of CQ and HCQ, and supportive treatments following toxicity occurs. It was believed that CQ and HCQ may provide few benefits to COVID-19 patients. A number of factors should be considered to keep the drug safe, such as dose, in vivo animal toxicological findings, and gathering of metabolites in plasma and/or tissues. The main conclusion of this review is that CQ and HCQ with considered to their ADMET properties has major shortcomings and fully irresponsible.